Sondra Neale Smyrnios
About Sondra Neale Smyrnios
Sondra Neale Smyrnios is the Senior Vice President, Head of Global Clinical Operations at Pyxis Oncology and Alkermes, with over 25 years of experience in clinical operations and research.
Title
Sondra Neale Smyrnios currently holds the position of Senior Vice President, Head of Global Clinical Operations at Pyxis Oncology. She also serves as Senior Vice President, Clinical Development Operations at Alkermes and is a Chief Founding Member at Chief.
Education and Expertise
Sondra Neale Smyrnios has a solid educational foundation in biological sciences. She earned a Bachelor of Science in Biology from Concordia University from 1987 to 1991, followed by a Master of Science in Teratology and Biology from McGill University from 1991 to 1993. Her academic background supports her extensive career in clinical operations and research, which spans over 25 years.
Professional Experience
Starting her career at Eli Lilly and Company as a Senior Clinical Research Associate from 1994 to 1998 in Toronto, Ontario, Canada, Sondra Neale Smyrnios has garnered extensive experience in various high-level roles. She worked at sanofi-aventis as Director of Clinical Research for five years, followed by roles at Kos Pharmaceuticals, Evia Clinical Services, and Omnicomm Systems Inc. Notably, she had a significant 13-year tenure at Alkermes, rising from Vice President, Clinical Operations to Senior Vice President. Currently, she works at Pyxis Oncology and is also involved in Chief.
Achievements at Alkermes
During her 13-year tenure at Alkermes, Sondra Neale Smyrnios played a crucial role in the clinical development and operations, contributing significantly to the company's growth in the biopharmaceutical sector. Her efforts spanned strategic planning and execution of clinical development programs, managing global clinical trials, and ensuring regulatory compliance.
Global Clinical Operations
With over 25 years of experience, Sondra Neale Smyrnios has a strong background in managing global clinical trials and ensuring adherence to regulatory standards. Her leadership roles across multiple companies have equipped her with a comprehensive understanding of clinical research and operations across various therapeutic areas.